- call +1-201-465-4211
- email sales@mrinsights.biz
Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
Scope of the Report:
This report studies the Metastatic Colorectal Cancer Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Metastatic Colorectal Cancer Treatment market by product type and applications/end industries.
Treatment of metastatic colorectal cancer is multidisciplinary field involving early evaluation for resection of hepatic metastasis, metastasectomy and coordinated chemotherapy or radiation therapy. Primary factors driving growth of metastatic colorectal cancer treatment market are increasing prevalence of colorectal cancer across the globe, rapid innovation in personalized medicine and discovery of new targets for treatment of colorectal cancers.
The global Metastatic Colorectal Cancer Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Metastatic Colorectal Cancer Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Surgery
Chemotherapy
Market Segment by Applications, can be divided into
Hospitals
Clinics
Cancer Research Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Metastatic Colorectal Cancer Treatment Market Overview
1.1 Product Overview and Scope of Metastatic Colorectal Cancer Treatment
1.2 Classification of Metastatic Colorectal Cancer Treatment by Types
1.2.1 Global Metastatic Colorectal Cancer Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Types in 2017
1.2.3 Surgery
1.2.4 Chemotherapy
1.3 Global Metastatic Colorectal Cancer Treatment Market by Application
1.3.1 Global Metastatic Colorectal Cancer Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centers
1.4 Global Metastatic Colorectal Cancer Treatment Market by Regions
1.4.1 Global Metastatic Colorectal Cancer Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Metastatic Colorectal Cancer Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Metastatic Colorectal Cancer Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Metastatic Colorectal Cancer Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Metastatic Colorectal Cancer Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Metastatic Colorectal Cancer Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Metastatic Colorectal Cancer Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Metastatic Colorectal Cancer Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 Metastatic Colorectal Cancer Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eli Lilly
2.3.1 Business Overview
2.3.2 Metastatic Colorectal Cancer Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Metastatic Colorectal Cancer Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Metastatic Colorectal Cancer Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Amgen
2.6.1 Business Overview
2.6.2 Metastatic Colorectal Cancer Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Amgen Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Taiho Oncology
2.7.1 Business Overview
2.7.2 Metastatic Colorectal Cancer Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Taiho Oncology Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Genentech
2.8.1 Business Overview
2.8.2 Metastatic Colorectal Cancer Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Genentech Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 EMD Serono
2.9.1 Business Overview
2.9.2 Metastatic Colorectal Cancer Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 EMD Serono Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Suzhou Zelgen Biopharmaceuticals
2.10.1 Business Overview
2.10.2 Metastatic Colorectal Cancer Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Metastatic Colorectal Cancer Treatment Market Competition, by Players
3.1 Global Metastatic Colorectal Cancer Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Metastatic Colorectal Cancer Treatment Players Market Share
3.2.2 Top 10 Metastatic Colorectal Cancer Treatment Players Market Share
3.3 Market Competition Trend
4 Global Metastatic Colorectal Cancer Treatment Market Size by Regions
4.1 Global Metastatic Colorectal Cancer Treatment Revenue and Market Share by Regions
4.2 North America Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
5 North America Metastatic Colorectal Cancer Treatment Revenue by Countries
5.1 North America Metastatic Colorectal Cancer Treatment Revenue by Countries (2013-2018)
5.2 USA Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
6 Europe Metastatic Colorectal Cancer Treatment Revenue by Countries
6.1 Europe Metastatic Colorectal Cancer Treatment Revenue by Countries (2013-2018)
6.2 Germany Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
6.4 France Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue by Countries
7.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue by Countries (2013-2018)
7.2 China Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
7.5 India Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
8 South America Metastatic Colorectal Cancer Treatment Revenue by Countries
8.1 South America Metastatic Colorectal Cancer Treatment Revenue by Countries (2013-2018)
8.2 Brazil Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Metastatic Colorectal Cancer Treatment by Countries
9.1 Middle East and Africa Metastatic Colorectal Cancer Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Metastatic Colorectal Cancer Treatment Revenue and Growth Rate (2013-2018)
10 Global Metastatic Colorectal Cancer Treatment Market Segment by Type
10.1 Global Metastatic Colorectal Cancer Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Metastatic Colorectal Cancer Treatment Market Forecast by Type (2018-2023)
10.3 Surgery Revenue Growth Rate (2013-2023)
10.4 Chemotherapy Revenue Growth Rate (2013-2023)
11 Global Metastatic Colorectal Cancer Treatment Market Segment by Application
11.1 Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Application (2013-2018)
11.2 Metastatic Colorectal Cancer Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Cancer Research Centers Revenue Growth (2013-2018)
12 Global Metastatic Colorectal Cancer Treatment Market Size Forecast (2018-2023)
12.1 Global Metastatic Colorectal Cancer Treatment Market Size Forecast (2018-2023)
12.2 Global Metastatic Colorectal Cancer Treatment Market Forecast by Regions (2018-2023)
12.3 North America Metastatic Colorectal Cancer Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Metastatic Colorectal Cancer Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue Market Forecast (2018-2023)
12.6 South America Metastatic Colorectal Cancer Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Metastatic Colorectal Cancer Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Metastatic Colorectal Cancer Treatment Picture
Table Product Specifications of Metastatic Colorectal Cancer Treatment
Table Global Metastatic Colorectal Cancer Treat
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
